tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX

Akari Therapeutics (AKTX) Technical Analysis

273 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Akari Therapeutics’s (AKTX) Moving Averages Convergence Divergence (MACD) indicator is 0.30, suggesting Akari Therapeutics is a Sell.
Akari Therapeutics’s (AKTX) 20-Day exponential moving average is 3.26, while Akari Therapeutics’s (AKTX) share price is $3.53, making it a Buy.
Akari Therapeutics’s (AKTX) 50-Day exponential moving average is 2.76, while Akari Therapeutics’s (AKTX) share price is $3.53, making it a Buy.

Akari Therapeutics (AKTX) Pivot Points

Jul 23, 2024, 05:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.26
3.45
3.54
3.73
3.82
4.01
4.10
Fibonacci
3.45
3.55
3.62
3.73
3.83
3.90
4.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akari Therapeutics (AKTX) Moving Averages

Jul 23, 2024, 05:06 AM
Period
Simple
Exponential
MA5
3.69Sell
3.60Sell
MA10
3.45Buy
3.49Buy
MA20
3.26Buy
3.26Buy
MA50
2.55Buy
2.76Buy
MA100
2.11Buy
2.51Buy
MA200
2.57Buy
2.82Buy
Akari Therapeutics’s (AKTX) 10-Day exponential moving average is 3.49, while Akari Therapeutics’s (AKTX) share price is $3.53, making it a Buy.
Akari Therapeutics’s (AKTX) 100-Day exponential moving average is 2.51, while Akari Therapeutics’s (AKTX) share price is $3.53, making it a Buy.
Akari Therapeutics’s (AKTX) stock price is $3.53 and Akari Therapeutics’s (AKTX) 50-day simple moving average is 2.55, creating a Buy signal.
Akari Therapeutics’s (AKTX) stock price is $3.53 and Akari Therapeutics’s (AKTX) 100-day simple moving average is 2.11, creating a Buy signal.
Akari Therapeutics’s (AKTX) stock price is $3.53 and Akari Therapeutics’s (AKTX) 200-day simple moving average is 2.57, creating a Buy signal.

Akari Therapeutics (AKTX) Technical Indicators

Jul 23, 2024, 05:06 AM
Name
Value
Implied Action
RSI (14)
58.84
Neutral
STOCH (9,6)
81.54
Sell
STOCHRSI (14)
81.98
Sell
MACD (12,26)
0.30
Sell
ADX (14)
38.18
Neutral
Williams %R
-30.89
Buy
CCI (14)
73.81
Neutral
ATR (14)
0.36
-
Ultimate Oscillator
46.19
Neutral
ROC
30.74
Buy
Akari Therapeutics’s (AKTX) Relative Strength Index (RSI) is 58.84, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Trend Strength Indicator (ADX) is 38.18, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Commodity Channel Index (CCI) is 73.81, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Price Rate of Change (ROC) is 30.74, creating a Buy signal.

FAQ

Is AKTX a Buy, Hold, or Sell?
Based on AKTX’s technical indicators, AKTX is a Buy.
    What is AKTX’s RSI (14)?
    AKTX’s RSI (14) is 58.84, which suggests AKTX is a Neutral.
      What is AKTX’s MACD?
      AKTX’s MACD is 0.30, which suggests AKTX is a Sell.
        What is AKTX’s 5-day moving average?
        AKTX’s 5-day moving average is 3.69, which suggests AKTX is a Sell.
          What is AKTX’s 20-day moving average?
          AKTX 20-day moving average is 3.26, which suggests AKTX is a Buy.
            What is AKTX’s 50-day moving average?
            AKTX’s 50-day moving average is 2.55, which suggests AKTX is a Buy.
              What is AKTX’s 200-day moving average?
              AKTX’s 200-day moving average is 2.57, which suggests AKTX is a Buy.
                What is AKTX’s Williams % R (14)?
                AKTX’s Williams % R (14) is -30.89, which suggests AKTX is a Buy.
                  What is AKTX’s CCI (14)?
                  AKTX’s CCI (14) is 73.81, which suggests AKTX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis